113 related articles for article (PubMed ID: 7845605)
1. Felbamate, an anti-convulsive drug, has anti-parkinsonian potential in rats.
Kretschmer BD
Neurosci Lett; 1994 Sep; 179(1-2):115-8. PubMed ID: 7845605
[TBL] [Abstract][Full Text] [Related]
2. D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptor participation in experimental catalepsy in rats.
Verma A; Kulkarni SK
Psychopharmacology (Berl); 1992; 109(4):477-83. PubMed ID: 1365866
[TBL] [Abstract][Full Text] [Related]
3. NMDA receptor antagonists inhibit catalepsy induced by either dopamine D1 or D2 receptor antagonists.
Moore NA; Blackman A; Awere S; Leander JD
Eur J Pharmacol; 1993 Jun; 237(1):1-7. PubMed ID: 8359205
[TBL] [Abstract][Full Text] [Related]
4. Opposite effects of NMDA and AMPA receptor blockade on catalepsy induced by dopamine receptor antagonists.
Papa SM; Engber TM; Boldry RC; Chase TN
Eur J Pharmacol; 1993 Mar; 232(2-3):247-53. PubMed ID: 8385618
[TBL] [Abstract][Full Text] [Related]
5. Felbamate block of the N-methyl-D-aspartate receptor.
Subramaniam S; Rho JM; Penix L; Donevan SD; Fielding RP; Rogawski MA
J Pharmacol Exp Ther; 1995 May; 273(2):878-86. PubMed ID: 7752093
[TBL] [Abstract][Full Text] [Related]
6. Felbamate, a novel antiepileptic drug, reverses N-methyl-D-aspartate/glycine-stimulated increases in intracellular Ca2+ concentration.
Taylor LA; McQuade RD; Tice MA
Eur J Pharmacol; 1995 Apr; 289(2):229-33. PubMed ID: 7621896
[TBL] [Abstract][Full Text] [Related]
7. Glycine site antagonists abolish dopamine D2 but not D1 receptor mediated catalepsy in rats.
Kretschmer BD; Winterscheid B; Danysz W; Schmidt WJ
J Neural Transm Gen Sect; 1994; 95(2):123-36. PubMed ID: 7865167
[TBL] [Abstract][Full Text] [Related]
8. Subtype-selective antagonism of N-methyl-D-aspartate receptors by felbamate: insights into the mechanism of action.
Kleckner NW; Glazewski JC; Chen CC; Moscrip TD
J Pharmacol Exp Ther; 1999 May; 289(2):886-94. PubMed ID: 10215667
[TBL] [Abstract][Full Text] [Related]
9. Haloperidol-induced catalepsy is absent in dopamine D(2), but maintained in dopamine D(3) receptor knock-out mice.
Boulay D; Depoortere R; Oblin A; Sanger DJ; Schoemaker H; Perrault G
Eur J Pharmacol; 2000 Mar; 391(1-2):63-73. PubMed ID: 10720636
[TBL] [Abstract][Full Text] [Related]
10. Blockade of subthalamic dopamine D1 receptors elicits akinesia in rats.
Hauber W
Neuroreport; 1998 Dec; 9(18):4115-8. PubMed ID: 9926857
[TBL] [Abstract][Full Text] [Related]
11. Excitoprotective effect of felbamate in cultured cortical neurons.
Kanthasamy AG; Matsumoto RR; Gunasekar PG; Trunong DD
Brain Res; 1995 Dec; 705(1-2):97-104. PubMed ID: 8821739
[TBL] [Abstract][Full Text] [Related]
12. Felbamate block of recombinant N-methyl-D-aspartate receptors: selectivity for the NR2B subunit.
Harty TP; Rogawski MA
Epilepsy Res; 2000 Mar; 39(1):47-55. PubMed ID: 10690753
[TBL] [Abstract][Full Text] [Related]
13. Evidence for anticonvulsant and neuroprotectant action of felbamate mediated by strychnine-insensitive glycine receptors.
McCabe RT; Wasterlain CG; Kucharczyk N; Sofia RD; Vogel JR
J Pharmacol Exp Ther; 1993 Mar; 264(3):1248-52. PubMed ID: 8383742
[TBL] [Abstract][Full Text] [Related]
14. Excitatory amino acid neurotransmission through both NMDA and non-NMDA receptors is involved in the anticonvulsant activity of felbamate in DBA/2 mice.
De Sarro G; Ongini E; Bertorelli R; Aguglia U; De Sarro A
Eur J Pharmacol; 1994 Sep; 262(1-2):11-9. PubMed ID: 7529182
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D1 or D2 receptor blockade in the globus pallidus produces akinesia in the rat.
Hauber W; Lutz S
Behav Brain Res; 1999 Dec; 106(1-2):143-50. PubMed ID: 10595430
[TBL] [Abstract][Full Text] [Related]
16. Re: Mazarati et al. "...clinically available [antiepileptic drug] with a moderate affinity for the glycine site of the N-methyl-D-aspartate (NMDA) receptor".
Rogawski MA; Wasterlain CG; Mazarati AM
Epilepsia; 2000 Jul; 41(7):918-9. PubMed ID: 10897169
[No Abstract] [Full Text] [Related]
17. The behavioural effects of pramipexole, a novel dopamine receptor agonist.
Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
Eur J Pharmacol; 1997 Apr; 324(1):31-7. PubMed ID: 9137910
[TBL] [Abstract][Full Text] [Related]
18. The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantation.
Shin E; Lisci C; Tronci E; Fidalgo C; Stancampiano R; Björklund A; Carta M
Neurobiol Dis; 2014 Feb; 62():233-40. PubMed ID: 24135006
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of the anticonvulsant felbamate: opposing effects on N-methyl-D-aspartate and gamma-aminobutyric acidA receptors.
Rho JM; Donevan SD; Rogawski MA
Ann Neurol; 1994 Feb; 35(2):229-34. PubMed ID: 8109904
[TBL] [Abstract][Full Text] [Related]
20. Reduction of dizocilpine and scopolamine-induced deficits in avoidance responding by SCH 54388, a metabolite of felbamate.
Smith RD; Grzelak ME; Coffin VL
Pharmacol Biochem Behav; 1997 Nov; 58(3):657-64. PubMed ID: 9329055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
